BIOMAT Database Logo BIOMAT Database Logo

ABC of monitoring drug therapy. Why monitor drug therapy? 1992

J K Aronson, and M Hardman
Radcliffe Infirmary, Oxford.

UI MeSH Term Description Entries
D004358 Drug Therapy The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER. Chemotherapy,Pharmacotherapy,Therapy, Drug,Chemotherapies,Drug Therapies,Pharmacotherapies,Therapies, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D016903 Drug Monitoring The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically. Monitoring, Drug,Therapeutic Drug Monitoring,Drug Monitoring, Therapeutic,Monitoring, Therapeutic Drug

Related Publications

J K Aronson, and M Hardman
ABC of monitoring drug therapy. Cyclosporin.
December 1992, BMJ (Clinical research ed.),
J K Aronson, and M Hardman
ABC of monitoring drug therapy. Lithium.
November 1992, BMJ (Clinical research ed.),
J K Aronson, and M Hardman
ABC of monitoring drug therapy. Aminoglycoside antibiotics.
December 1992, BMJ (Clinical research ed.),
J K Aronson, and M Hardman
Intracranial pressure monitoring: why monitor?
January 2005, AACN clinical issues,
J K Aronson, and M Hardman
ABC of monitoring drug therapy. Making the most of plasma drug concentration measurements.
January 1993, BMJ (Clinical research ed.),
J K Aronson, and M Hardman
[Monitoring of therapy using drug concentration levels: Why? When? How?].
August 1990, Therapeutische Umschau. Revue therapeutique,
J K Aronson, and M Hardman
Why monitor?
October 1976, Anesthesia progress,
J K Aronson, and M Hardman
Monitoring drug therapy.
June 2012, British journal of clinical pharmacology,
J K Aronson, and M Hardman
Anaesthesia workstation monitor: why surgeons should monitor?
August 2021, BMJ case reports,
J K Aronson, and M Hardman
Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
August 2019, Korean journal of pediatrics,
Copied contents to your clipboard!